Merck & Co., Inc.

NYSE:MRK

Drug Manufacturers - General

Healthcare
$137.78 -1.14%

-$1.32 today

Market cap
$339.66B
Beta
0.22
P/E (TTM)
31.6
EPS (TTM)
$3.61
Dividend yield
2.94%
52W Low $76.66High $125.14

Volume 9.69M

Average 11.85M

MRK Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Merck & Co., Inc.NYSE: MRK

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares declines year over year

Q2 FY2026 weighted avg shares of 2.47B shares fell 1.5% year over year, in line with the -2.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -0.4% a year.

Context

  • Weighted avg shares increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -1.5% holds above the trailing-twelve-month pace of -2.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
2.47B+0.0% QoQ
Last fiscal yearDec 2025
2.5B-1.2% YoY
LTMJun 2026
2.48B-2.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.5%——
1 year-1.2%——
3-year CAGR-0.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
2.5B USD
Year-over-year change
-1.2%
4-year CAGR
-0.3%

Weighted Avg Shares vs competitors

How MRK compares with its peers on the latest reported figures

  • MRK's LTM Jun 2026 weighted avg shares of 2.48B shares is the 2nd highest of the 10 companies compared; the peer median is 1.77B shares.
  • Its year-over-year change of -2.0% is the 8th highest of 10, against a peer median of -0.2%.
  • Over three fiscal years its annual growth of -0.4% compares with a peer median of -0.3%.
MRK Competitors Peer median
Weighted Avg Shares for MRK and competitors
Company Period LTM YoY 3-year CAGR
PFEPfizer Inc.LTM Jun 20265.69B +0.3%+0.4%
MRKMerck & Co., Inc.LTM Jun 20262.48B -2.0%-0.4%
JNJJohnson & JohnsonLTM Sep 20262.44B +1.0%-2.4%
SNYSanofiLTM Jun 20262.42B -2.7%-0.8%
NVSNovartis AGLTM Jun 20261.91B -3.3%-3.8%
ABBVAbbVie Inc.LTM Sep 20261.77B +0.1%+0.1%
AZNAstraZeneca PLCLTM Sep 20261.55B -0.2%+0.0%
GILDGilead Sciences, Inc.LTM Jun 20261.24B -0.3%-0.3%
LLYEli Lilly and CompanyLTM Jun 2026895.45M -0.4%-1.9%
AMGNAmgen Inc.LTM Jun 2026539.25M +0.2%+0.0%
Peer median (excluding MRK) 1.77B-0.2%-0.3%

Competitors are the stored peer set for MRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue48.7B59.28B60.12B64.17B64.93B
Cost of Revenue13.63B17.41B16.13B15.19B18.2B
Gross Profit35.08B41.87B43.99B48.98B46.73B
Gross Margin72.0%70.6%73.2%76.3%72.0%
Research & Development12.25B13.55B30.53B17.94B12.51B
Selling, General & Admin9.4B9.67B9.88B10.1B10.73B
Operating Expenses21.88B23.59B41.04B28.75B23.25B
Depreciation & Amortization3.21B3.91B3.87B4.5B5.84B
EBITDA17.9B21.32B6.91B25.71B28.26B
EBITDA Margin36.8%36.0%11.5%40.1%43.5%
Operating Income13.2B18.28B2.95B20.22B23.49B
Operating Margin27.1%30.8%4.9%31.5%36.2%
Interest Income36M157M365M415M343M
Interest Expense806M962M1.15B1.27B1.36B
Other Income / Expenses680M(1.84B)(1.07B)(285M)(2.42B)
Income Before Tax13.88B16.44B1.89B19.94B21.07B
Pre-Tax Margin28.5%27.7%3.1%31.1%32.4%
Income Tax Expense1.52B1.92B1.51B2.8B2.8B
Net Income13.05B14.52B365M17.12B18.25B
Net Margin26.8%24.5%0.6%26.7%28.1%
EPS (Basic)5.165.730.146.767.30
EPS (Diluted)5.145.710.146.747.28
Weighted Avg Shares2.53B2.53B2.55B2.53B2.5B
Weighted Avg Shares (Diluted)2.54B2.54B2.55B2.54B2.51B

Merck & Co., Inc.

NYSE:MRK

Intrinsic Alpha fair value

Locked

Current Price

$137.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.